Mathiassen Ole N, Buus Niels H, Sihm Inger, Thybo Niels K, Mørn Birgitte, Schroeder Anne P, Thygesen Kristian, Aalkjaer Christian, Lederballe Ole, Mulvany Michael J, Christensen Kent L
Department of Pharmacology, University of Aarhus, Denmark.
J Hypertens. 2007 May;25(5):1021-6. doi: 10.1097/HJH.0b013e32805bf8ed.
Structural abnormality of resistance arteries is a characteristic pathophysiological phenomenon in essential hypertension and can be assessed in vitro as an increase in the media: lumen ratio (M: L) of isolated small arteries. We have investigated whether M: L is a risk predictor in uncomplicated essential hypertensive patients. Recently, high M: L was demonstrated as a prognostic marker in patients at high cardiovascular risk, including normotensive type 2 diabetic patients. Since diabetes is associated with pressure-independent changes in M: L, the relevance of this finding to essential hypertension has been uncertain.
We conducted a follow-up survey of 159 essential hypertensive patients, who had previously been submitted to a M: L evaluation while participating in a clinical trial. They composed a homogeneous moderate-risk group, with no concomitant diseases, and represented 1661 years of follow-up.
Thirty patients suffered a documented predefined cardiovascular event during follow-up. Increased relative risk (RR) was associated with M: L >or= 0.083 (mean level of the hypertensive cohort), RR = 2.34 [95% confidence interval (CI) 1.11-4.95], and with M: L >or= 0.098 (mean level of a normotensive control group + 2SD), RR = 2.49 (95% CI 1.21-5.11). Both results remained significant (RR = 2.19, 95% CI 1.04-4.64, and RR = 2.20, 95% CI 1.06-4.56, respectively) when adjusted for Heart Score level (10-year mortality risk-estimate, integrating age, gender, systolic blood pressure, cholesterol and smoking).
Abnormal resistance artery structure independently predicts cardiovascular events in essential hypertensive patients at moderate risk.
阻力动脉结构异常是原发性高血压的一种典型病理生理现象,可通过体外检测孤立小动脉的中膜与管腔比值(M:L)升高来评估。我们研究了M:L是否为未合并并发症的原发性高血压患者的风险预测指标。最近,高M:L被证明是包括血压正常的2型糖尿病患者在内的高心血管风险患者的预后标志物。由于糖尿病与M:L的压力非依赖性变化有关,这一发现与原发性高血压的相关性尚不确定。
我们对159例原发性高血压患者进行了随访调查,这些患者在参与一项临床试验时曾接受过M:L评估。他们构成了一个无合并症的同质中度风险组,随访时间总计1661人年。
30例患者在随访期间发生了记录在案的预定义心血管事件。M:L≥0.083(高血压队列的平均水平)时相对风险(RR)增加,RR = 2.34 [95%置信区间(CI)1.11 - 4.95];M:L≥0.098(血压正常对照组平均水平 + 2SD)时,RR = 2.49(95% CI 1.21 - 5.11)。在根据心脏评分水平(整合年龄、性别、收缩压、胆固醇和吸烟情况的10年死亡风险估计值)进行调整后,两个结果仍具有显著性(RR分别为2.19,95% CI 1.04 - 4.64和RR = 2.20,95% CI 1.06 - 4.56)。
阻力动脉结构异常可独立预测中度风险的原发性高血压患者发生心血管事件。